Citrasate Liquid Acid Concentrate, NaturaLyte Liquid Acid Concentrate
K-Number: K212620 · 2022-05-12
Device Summary
Frequently Asked Questions
What is the Citrasate Liquid Acid Concentrate, NaturaLyte Liquid Acid Concentrate?
Citrasate Liquid Acid Concentrate, NaturaLyte Liquid Acid Concentrate is a medical device that received FDA 510(k) clearance on 2022-05-12. It is manufactured by Fresenius Medical Care Renal Therapies Group, LLC. The 510(k) number is K212620.
When was Citrasate Liquid Acid Concentrate, NaturaLyte Liquid Acid Concentrate approved by the FDA?
Citrasate Liquid Acid Concentrate, NaturaLyte Liquid Acid Concentrate received FDA 510(k) clearance on 2022-05-12, under approval number K212620.
What company makes Citrasate Liquid Acid Concentrate, NaturaLyte Liquid Acid Concentrate?
Citrasate Liquid Acid Concentrate, NaturaLyte Liquid Acid Concentrate is manufactured by Fresenius Medical Care Renal Therapies Group, LLC.
What is the FDA product code for Citrasate Liquid Acid Concentrate, NaturaLyte Liquid Acid Concentrate?
The FDA product code for Citrasate Liquid Acid Concentrate, NaturaLyte Liquid Acid Concentrate is KPO.
Related Clinical Trials
Other Devices by Fresenius Medical Care Renal Therapies Group, LLC
Related Devices (Code: KPO)
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.